Advertisement
Screener

DAVITA INC. (DVA) Borrowing debt

DAVITA INC. (DVA) Borrowing debt

  • Total debt · latest quarter (USD): Value (m); Formula and calculation Current and noncurrent long-term debt plus complete reported short-term borrowings (commercial paper alone when no complete total is admitted). Period ending 2014-09-30..
  • Net cash · latest quarter: Value (m); Formula and calculation Cash and cash equivalents plus current marketable securities less interest-bearing debt; negative net cash is displayed as net debt. Period ending 2014-09-30..
  • Debt / assets · latest quarter: Value (m); Formula and calculation Current and noncurrent long-term debt plus complete reported short-term borrowings (commercial paper alone when no complete total is admitted) / total assets. Period ending 2014-09-30..

Borrowing debt

Overview →

Financial period ending 2014-09-30; current quote (m). Amounts retain their stated periods and units.

MetricValueFormula and calculation
Total debt · latest quarter (USD)(m)Current and noncurrent long-term debt plus complete reported short-term borrowings (commercial paper alone when no complete total is admitted). Period ending 2014-09-30.

Calculation unavailable: missing inputs remain (m).

Net cash · latest quarter(m)Cash and cash equivalents plus current marketable securities less interest-bearing debt; negative net cash is displayed as net debt. Period ending 2014-09-30.

Calculation unavailable: missing inputs remain (m).

Debt / assets · latest quarter(m)Current and noncurrent long-term debt plus complete reported short-term borrowings (commercial paper alone when no complete total is admitted) / total assets. Period ending 2014-09-30.

Calculation unavailable: missing inputs remain (m).

Calculation inputs

InputAmount with unitRaw financial data
Borrowing debt due within one year121.53M USDLong-term Debt, Current Maturities
Borrowing debt due after one year(m)Long-term Debt, Excluding Current Maturities
Commercial paper(m)
Cash and current securities(m)Cash and Cash Equivalents, at Carrying Value · Marketable Securities, Current · Available-for-sale Securities, Current
Borrowing debt(m)Long-term Debt, Current Maturities · Long-term Debt, Excluding Current Maturities
Total assets18.10B USDAssets

Calculated history

Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.

Period endingTotal debtNet cash / debtBorrowing debt due within one year (USD)Borrowing debt due after one year (USD)Commercial paper (USD)Cash and current securities (USD)Total assets (USD)Debt / assets
2014-09-30(m)(m)$121.53M(m)(m)(m)$18.10B(m)
2014-06-30(m)(m)$117.08M(m)(m)(m)$17.93B(m)
2013-12-31(m)(m)$274.70M(m)(m)(m)$17.10B(m)
2012-09-30(m)(m)$117.82M$5.62B(m)(m)$10.82B(m)
2012-06-30(m)(m)$105.56M$4.39B(m)(m)$9.25B(m)
2012-03-31(m)(m)$89.65M$4.40B(m)(m)$9.16B(m)
2011-12-31(m)(m)$87.34M$4.42B(m)(m)$8.89B(m)
2011-09-30(m)(m)$82.50M$4.42B(m)(m)$8.71B(m)
2011-06-30(m)(m)$75.23M$4.21B(m)(m)$8.19B(m)
2011-03-31(m)(m)$74.55M$4.22B(m)(m)$8.32B(m)
2010-12-31(m)(m)$74.89M$4.23B(m)(m)$8.11B(m)
2010-09-30(m)(m)$96.25M$3.27B(m)(m)$7.63B(m)
2010-06-30(m)(m)$96.59M$3.29B(m)(m)$7.58B(m)
2010-03-31(m)(m)$98.84M$3.51B(m)(m)$7.69B(m)
2009-12-31(m)(m)$100.01M$3.53B(m)(m)$7.56B(m)
2009-09-30(m)(m)$100.68M$3.56B(m)(m)$7.54B(m)
2009-06-30(m)(m)$92.29M$3.58B(m)(m)$7.44B(m)
2008-12-31(m)(m)$72.72M$3.62B(m)(m)$7.29B(m)

(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.

Similar stocks

Stock NameCountryMarket CapPE Ratio
Sotera Health Co (SHC)United States$5.271B30.96
Progyny, Inc. (PGNY)United States$1.994B28.37
agilon health, inc. (AGL)United States$1.272B-7.76
VIEMED HEALTHCARE, INC. (VMD)United States$0.336B29.92
Park Dental Partners, Inc. (PARK)United States$0.094B
BioRestorative Therapies, Inc. (BRTX)United States$0.064B
CRYO CELL INTERNATIONAL INC (CCEL)United States$0.033B-11.02
MANGOCEUTICALS, INC. (MGRX)United States$0.010B-0.43